Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-231341
Filing Date
2020-08-26
Accepted
2020-08-26 16:42:52
Documents
2
Group Members
COLUMN GROUP II GP, LPCOLUMN GROUP II MANAGEMENT, LPDAVID V. GOEDDELPETER SVENNILSONPONOI CAPITAL II, LPPONOI CAPITAL, LPPONOI II MANAGEMENT, LLCPONOI MANAGEMENT, LLCTIM KUTZKEY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d946263dsc13da.htm SC 13D/A 175502
2 EX-99.A d946263dex99a.htm EX-99.A 10766
  Complete submission text file 0001193125-20-231341.txt   188181
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

EIN.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Subject) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91191 | Film No.: 201137742
SIC: 2834 Pharmaceutical Preparations